MedAire and Aerosafety, its Brazil-based strategic partner, have received approval from Brazil’s aviation regulator ANAC for new emergency medical kits for corporate aircraft. Brazil’s ANVISA health regulatory agency has also issued its approval.

The two companies are exhibiting at LABACE together this week (Booth 3006). The partnership between MedAire and Aerosafety covers 24/7 medical and security assistance and crew medical training.

The first product launched under the new approvals is MedAire’s Emergency Medical Kit, which contains “important prescriptions to assist flight crew in stabilizing passengers with critical illnesses or injuries.”

The companies said in a statement released yesterday that “aviation clients now have local access to lifesaving medications for stabilizing unwell passengers in flight. We will be the only group in the region to have this approval and capability. Medical and drug standards vary drastically throughout the world.

“Medications present in this kit are recommended based on MedAire’s worldwide experience to address the most common and severe events that may occur in flight,” said Paulo Alves, MedAire global medical director. “The certifications obtained both from aviation and health regulators in Brazil are undoubtedly a testimony to the quality and compliance standards of our partner in that country.”

Aerosafety senior consultant Yavor Luketic told AIN at LABACE yesterday that “no other company has an ANVISA license for aviation.” He added that AeroSafety has 85 percent of the Brazilian market for medical kits on aircraft. “We do all the kits for the airlines Azul, GOL etc. And we do all the escape slide servicing for GOL."